Waters... noitazilaicremmoC dna tnempole

Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Research
上一篇:Every... 2202 seluR nehctiK yM morf det
下一篇:T-Mobile... nlb 53.1$ rof eliboM tniM dekc